-+ 0.00%
-+ 0.00%
-+ 0.00%

Neuronetics publishes investor presentation on NeuroStar TMS, Greenbrook clinic network strategy

PUBT·08/11/2026 12:13:37
Listen to the news
Neuronetics publishes investor presentation on NeuroStar TMS, Greenbrook clinic network strategy
  • Neuronetics outlined FY 2026 revenue guidance of USD 160 million to USD 164 million, implying 7% to 10% year-on-year growth.
  • Gross margin outlook set at 48% to 50%.
  • Operating expenses projected at USD 91 million to USD 96 million, excluding about USD 4 million of non-cash stock-based compensation.
  • Cash flow from operations and investing forecast at negative USD 10.5 million to negative USD 14.5 million.
  • Second-quarter revenue reported at USD 41.57 million, up 9% year-on-year; adjusted EBITDA turned positive at USD 0.25 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuronetics Inc. published the original content used to generate this news brief on August 11, 2026, and is solely responsible for the information contained therein.